Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Lung Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Liver Neoplasms 2Breast Neoplasms, Male 2Sarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Melanoma 1Kidney Neoplasms 1Hepatitis C 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Fallopian Tube Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Brain Neoplasms 1

Interventions

Radiotherapy 3Temozolomide 2Tamoxifen 2Magnetic Resonance Spectroscopy 2sargramostim 1aldesleukin 1Topotecan 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Muromonab-CD3 1Modafinil 1Mental Status and Dementia Tests 1Lapatinib 1Immunologic Techniques 1Immunoenzyme Techniques 1Imatinib Mesylate 1Ginkgo biloba extract 1Gefitinib 1FANG vaccine 1Drug Therapy 1Doxorubicin 1Donepezil 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Glioma, Subependymal × Immunoenzyme Techniques × Clear all
NCT00498927 2016-02-29

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
47 enrolled 7 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡